Is there any role of thrombin activatable fibrinolysis inhibitor in the development of a hypercoagulable state in gastric cancer


ESER M., KEMENT M., BALIN S., COSKUN C., KEFELI U., Gumus M. , et al.

WORLD JOURNAL OF SURGICAL ONCOLOGY, cilt.10, 2012 (SCI İndekslerine Giren Dergi)

  • Cilt numarası: 10
  • Basım Tarihi: 2012
  • Doi Numarası: 10.1186/1477-7819-10-180
  • Dergi Adı: WORLD JOURNAL OF SURGICAL ONCOLOGY

Özet

Background: The purpose of this study was to investigate plasma levels of thrombin activatable fibrinolysis inhibitor (TAFI) and TAFI's relationship with coagulation markers (prothrombin fragment 1 + 2) in gastric cancer patients.